Cargando…

Clinical characteristics and therapeutic strategy of granulomatous mastitis accompanied by Corynebacterium kroppenstedtii: a retrospective cohort study

BACKGROUND: Increasing evidence has suggested that Corynebacterium kroppenstedtii is associated with some cases of granulomatous mastitis, mostly based on pathology or microbiology. We aimed to identify the clinical characteristics and treatment regimens for granulomatous mastitis with Corynebacteri...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, ShunBo, Huang, Qian, Song, PeiPei, Han, XiaoRong, Liu, ZeYu, Zhou, Lin, Ning, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369769/
https://www.ncbi.nlm.nih.gov/pubmed/37491234
http://dx.doi.org/10.1186/s12905-023-02509-7
_version_ 1785077830511493120
author Li, ShunBo
Huang, Qian
Song, PeiPei
Han, XiaoRong
Liu, ZeYu
Zhou, Lin
Ning, Ping
author_facet Li, ShunBo
Huang, Qian
Song, PeiPei
Han, XiaoRong
Liu, ZeYu
Zhou, Lin
Ning, Ping
author_sort Li, ShunBo
collection PubMed
description BACKGROUND: Increasing evidence has suggested that Corynebacterium kroppenstedtii is associated with some cases of granulomatous mastitis, mostly based on pathology or microbiology. We aimed to identify the clinical characteristics and treatment regimens for granulomatous mastitis with Corynebacterium kroppenstedtii infection. Understanding these clinical features is essential for patient care. METHODS: We retrospectively collected data on 201 patients who were pathologically diagnosed with granulomatous mastitis and had microbiological results of either Corynebacterium kroppenstedtii or no bacterial growth and recorded and analysed their demographics, clinical characteristics, and clinical outcomes. RESULTS: There were 107 patients in the CK group and 94 patients in the negative group. Sinus formation (x(2) = 13.028, p = 0.000), time to complete remission at the first treatment period (Z = -3.027, p = 0.002), diameter of breast mass at first-time medical consultancy (Z = -2.539, p = 0.011) and recurrence (x(2) = 4.953, p = 0.026) were statistically significant. Age (Z = -1.046, p = 0.295), laterality (x(2) = 4.217, p = 0.121), time to presentation since the last delivery (x(2) = 0.028, p = 0.868), BMI (Z = -0.947, p = 0.344), lactation time (Z = -1.378, p = 0.168), parity (x(2) = 1.799, p = 0.180), gravida (Z = -0.144, p = 0.885), history of lactational mastitis or abscess (x(2) = 0.115, p = 0.734), local trauma (x(2) = 0.982, p = 0.322), hyperprolactinemia (x(2) = 0.706, p = 0.401), erythema nodosum (x(2) = 0.292, p = 0.589), and nipple discharge (x(2) = 0.281, p = 0.596) did not demonstrate statistical significance. Regarding recurrence related to therapeutic strategy, except for surgery combined with immunosuppressants (x(2) = 9.110, p = 0.003), which was statistically significant, none of the other treatment regimens reached statistical significance. The recurrence rate of patients in the CK group using rifampicin in their treatment course was 22.0% (x(2) = 4.892, p = 0.027). CONCLUSIONS: Granulomatous mastitis accompanied by Corynebacterium kroppenstedtii more easily forms sinuses and has a higher recurrence rate. Both of the clinical characteristics may indicate that Corynebacterium kroppenstedtii plays an important role in the development and progression of granulomatous mastitis. Lipophilic antibiotics may be essential for granulomatous mastitis with Corynebacterium kroppenstedtii infection.
format Online
Article
Text
id pubmed-10369769
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-103697692023-07-27 Clinical characteristics and therapeutic strategy of granulomatous mastitis accompanied by Corynebacterium kroppenstedtii: a retrospective cohort study Li, ShunBo Huang, Qian Song, PeiPei Han, XiaoRong Liu, ZeYu Zhou, Lin Ning, Ping BMC Womens Health Research Article BACKGROUND: Increasing evidence has suggested that Corynebacterium kroppenstedtii is associated with some cases of granulomatous mastitis, mostly based on pathology or microbiology. We aimed to identify the clinical characteristics and treatment regimens for granulomatous mastitis with Corynebacterium kroppenstedtii infection. Understanding these clinical features is essential for patient care. METHODS: We retrospectively collected data on 201 patients who were pathologically diagnosed with granulomatous mastitis and had microbiological results of either Corynebacterium kroppenstedtii or no bacterial growth and recorded and analysed their demographics, clinical characteristics, and clinical outcomes. RESULTS: There were 107 patients in the CK group and 94 patients in the negative group. Sinus formation (x(2) = 13.028, p = 0.000), time to complete remission at the first treatment period (Z = -3.027, p = 0.002), diameter of breast mass at first-time medical consultancy (Z = -2.539, p = 0.011) and recurrence (x(2) = 4.953, p = 0.026) were statistically significant. Age (Z = -1.046, p = 0.295), laterality (x(2) = 4.217, p = 0.121), time to presentation since the last delivery (x(2) = 0.028, p = 0.868), BMI (Z = -0.947, p = 0.344), lactation time (Z = -1.378, p = 0.168), parity (x(2) = 1.799, p = 0.180), gravida (Z = -0.144, p = 0.885), history of lactational mastitis or abscess (x(2) = 0.115, p = 0.734), local trauma (x(2) = 0.982, p = 0.322), hyperprolactinemia (x(2) = 0.706, p = 0.401), erythema nodosum (x(2) = 0.292, p = 0.589), and nipple discharge (x(2) = 0.281, p = 0.596) did not demonstrate statistical significance. Regarding recurrence related to therapeutic strategy, except for surgery combined with immunosuppressants (x(2) = 9.110, p = 0.003), which was statistically significant, none of the other treatment regimens reached statistical significance. The recurrence rate of patients in the CK group using rifampicin in their treatment course was 22.0% (x(2) = 4.892, p = 0.027). CONCLUSIONS: Granulomatous mastitis accompanied by Corynebacterium kroppenstedtii more easily forms sinuses and has a higher recurrence rate. Both of the clinical characteristics may indicate that Corynebacterium kroppenstedtii plays an important role in the development and progression of granulomatous mastitis. Lipophilic antibiotics may be essential for granulomatous mastitis with Corynebacterium kroppenstedtii infection. BioMed Central 2023-07-25 /pmc/articles/PMC10369769/ /pubmed/37491234 http://dx.doi.org/10.1186/s12905-023-02509-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Li, ShunBo
Huang, Qian
Song, PeiPei
Han, XiaoRong
Liu, ZeYu
Zhou, Lin
Ning, Ping
Clinical characteristics and therapeutic strategy of granulomatous mastitis accompanied by Corynebacterium kroppenstedtii: a retrospective cohort study
title Clinical characteristics and therapeutic strategy of granulomatous mastitis accompanied by Corynebacterium kroppenstedtii: a retrospective cohort study
title_full Clinical characteristics and therapeutic strategy of granulomatous mastitis accompanied by Corynebacterium kroppenstedtii: a retrospective cohort study
title_fullStr Clinical characteristics and therapeutic strategy of granulomatous mastitis accompanied by Corynebacterium kroppenstedtii: a retrospective cohort study
title_full_unstemmed Clinical characteristics and therapeutic strategy of granulomatous mastitis accompanied by Corynebacterium kroppenstedtii: a retrospective cohort study
title_short Clinical characteristics and therapeutic strategy of granulomatous mastitis accompanied by Corynebacterium kroppenstedtii: a retrospective cohort study
title_sort clinical characteristics and therapeutic strategy of granulomatous mastitis accompanied by corynebacterium kroppenstedtii: a retrospective cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369769/
https://www.ncbi.nlm.nih.gov/pubmed/37491234
http://dx.doi.org/10.1186/s12905-023-02509-7
work_keys_str_mv AT lishunbo clinicalcharacteristicsandtherapeuticstrategyofgranulomatousmastitisaccompaniedbycorynebacteriumkroppenstedtiiaretrospectivecohortstudy
AT huangqian clinicalcharacteristicsandtherapeuticstrategyofgranulomatousmastitisaccompaniedbycorynebacteriumkroppenstedtiiaretrospectivecohortstudy
AT songpeipei clinicalcharacteristicsandtherapeuticstrategyofgranulomatousmastitisaccompaniedbycorynebacteriumkroppenstedtiiaretrospectivecohortstudy
AT hanxiaorong clinicalcharacteristicsandtherapeuticstrategyofgranulomatousmastitisaccompaniedbycorynebacteriumkroppenstedtiiaretrospectivecohortstudy
AT liuzeyu clinicalcharacteristicsandtherapeuticstrategyofgranulomatousmastitisaccompaniedbycorynebacteriumkroppenstedtiiaretrospectivecohortstudy
AT zhoulin clinicalcharacteristicsandtherapeuticstrategyofgranulomatousmastitisaccompaniedbycorynebacteriumkroppenstedtiiaretrospectivecohortstudy
AT ningping clinicalcharacteristicsandtherapeuticstrategyofgranulomatousmastitisaccompaniedbycorynebacteriumkroppenstedtiiaretrospectivecohortstudy